ReP USP - Resultado da busca

Artigo de periodico
ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia (2022)
Luizon, Marcelo Rizzatti; Pinto-Souza, Caroline C.; Coeli-Lacchini, Fernanda Borchers; Lacchini, Riccardo ; Cavalli, Ricardo de Carvalho; Sandrim, Valéria Cristina
Fonte: Pharmacogenomics. Unidades: FMRP, EERP
Assuntos: POLIMORFISMO, HIPERTENSÃO, ÓXIDO NÍTRICO, NITRITOS, FARMACOGENÉTICA, PRÉ-ECLÂMPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZON, Marcelo Rizzatti et al. ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia. Pharmacogenomics, v. 23, n. 13, p. 713-722, 2022Tradução . . Disponível em: https://doi.org/10.2217/pgs-2022-0079. Acesso em: 28 jul. 2024.
APA
Luizon, M. R., Pinto-Souza, C. C., Coeli-Lacchini, F. B., Lacchini, R., Cavalli, R. de C., & Sandrim, V. C. (2022). ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia. Pharmacogenomics, 23( 13), 713-722. doi:10.2217/pgs-2022-0079
NLM
Luizon MR, Pinto-Souza CC, Coeli-Lacchini FB, Lacchini R, Cavalli R de C, Sandrim VC. ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2022 ; 23( 13): 713-722.[citado 2024 jul. 28 ] Available from: https://doi.org/10.2217/pgs-2022-0079
Vancouver
Luizon MR, Pinto-Souza CC, Coeli-Lacchini FB, Lacchini R, Cavalli R de C, Sandrim VC. ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2022 ; 23( 13): 713-722.[citado 2024 jul. 28 ] Available from: https://doi.org/10.2217/pgs-2022-0079
Artigo de periodico
Effects of arginase genetic polymorphisms on nitric oxide formation in healthy pregnancy and in preeclampsia (2021)
Pinto-Souza, Caroline Cristina; Coeli-Lacchini, Fernanda Borchers; Luizon, Marcelo Rizzatti; Cavalli, Ricardo de Carvalho; Lacchini, Riccardo ; Sandrim, Valéria Cristina
Fonte: Nitric Oxide. Unidades: FMRP, EERP, FCFRP
Assuntos: ÓXIDO NÍTRICO, NITRITOS, PRÉ-ECLÂMPSIA, POLIMORFISMO, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO-SOUZA, Caroline Cristina et al. Effects of arginase genetic polymorphisms on nitric oxide formation in healthy pregnancy and in preeclampsia. Nitric Oxide, v. 109–110, p. 20-25, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.niox.2021.02.003. Acesso em: 28 jul. 2024.
APA
Pinto-Souza, C. C., Coeli-Lacchini, F. B., Luizon, M. R., Cavalli, R. de C., Lacchini, R., & Sandrim, V. C. (2021). Effects of arginase genetic polymorphisms on nitric oxide formation in healthy pregnancy and in preeclampsia. Nitric Oxide, 109–110, 20-25. doi:10.1016/j.niox.2021.02.003
NLM
Pinto-Souza CC, Coeli-Lacchini FB, Luizon MR, Cavalli R de C, Lacchini R, Sandrim VC. Effects of arginase genetic polymorphisms on nitric oxide formation in healthy pregnancy and in preeclampsia [Internet]. Nitric Oxide. 2021 ; 109–110 20-25.[citado 2024 jul. 28 ] Available from: https://doi.org/10.1016/j.niox.2021.02.003
Vancouver
Pinto-Souza CC, Coeli-Lacchini FB, Luizon MR, Cavalli R de C, Lacchini R, Sandrim VC. Effects of arginase genetic polymorphisms on nitric oxide formation in healthy pregnancy and in preeclampsia [Internet]. Nitric Oxide. 2021 ; 109–110 20-25.[citado 2024 jul. 28 ] Available from: https://doi.org/10.1016/j.niox.2021.02.003
Artigo de periodico
Interaction between NOS3 and HMOX1 on antihypertensive drug responsiveness in preeclampsia (2020)
Sandrim, Valéria Cristina; Luizon, Marcelo Rizzatti; Pilan, Eliane; Dias, Mayara Caldeira; Coeli-Lacchini, Fernanda Borchers; Kors, Georgia; Berndt, Iuly; Lacchini, Riccardo ; Cavalli, Ricardo de Carvalho
Fonte: Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics. Unidades: EERP, FMRP, FCFRP
Assuntos: PRÉ-ECLÂMPSIA, POLIMORFISMO, ANTIOXIDANTES, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANDRIM, Valéria Cristina et al. Interaction between NOS3 and HMOX1 on antihypertensive drug responsiveness in preeclampsia. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics, v. 42, n. 8, p. 460-467, 2020Tradução . . Disponível em: https://doi.org/10.1055/s-0040-1712484. Acesso em: 28 jul. 2024.
APA
Sandrim, V. C., Luizon, M. R., Pilan, E., Dias, M. C., Coeli-Lacchini, F. B., Kors, G., et al. (2020). Interaction between NOS3 and HMOX1 on antihypertensive drug responsiveness in preeclampsia. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics, 42( 8), 460-467. doi:10.1055/s-0040-1712484
NLM
Sandrim VC, Luizon MR, Pilan E, Dias MC, Coeli-Lacchini FB, Kors G, Berndt I, Lacchini R, Cavalli R de C. Interaction between NOS3 and HMOX1 on antihypertensive drug responsiveness in preeclampsia [Internet]. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics. 2020 ; 42( 8): 460-467.[citado 2024 jul. 28 ] Available from: https://doi.org/10.1055/s-0040-1712484
Vancouver
Sandrim VC, Luizon MR, Pilan E, Dias MC, Coeli-Lacchini FB, Kors G, Berndt I, Lacchini R, Cavalli R de C. Interaction between NOS3 and HMOX1 on antihypertensive drug responsiveness in preeclampsia [Internet]. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics. 2020 ; 42( 8): 460-467.[citado 2024 jul. 28 ] Available from: https://doi.org/10.1055/s-0040-1712484
Artigo de periodico
Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia (2019)
Sandrim, Valéria Cristina ; Coeli-Lacchini, Fernanda Borchers ; Tanus-Santos, José Eduardo ; Lacchini, Riccardo ; Cavalli, Ricardo de Carvalho
Fonte: Hypertension in Pregnancy. Unidades: FMRP, EERP, FCFRP
Assuntos: POLIMORFISMO, PRÉ-ECLÂMPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANDRIM, Valéria Cristina et al. Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia. Hypertension in Pregnancy, v. 38, n. 2, p. 73-77, 2019Tradução . . Disponível em: https://doi.org/10.1080/10641955.2019.1582664. Acesso em: 28 jul. 2024.
APA
Sandrim, V. C., Coeli-Lacchini, F. B., Tanus-Santos, J. E., Lacchini, R., & Cavalli, R. de C. (2019). Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia. Hypertension in Pregnancy, 38( 2), 73-77. doi:10.1080/10641955.2019.1582664
NLM
Sandrim VC, Coeli-Lacchini FB, Tanus-Santos JE, Lacchini R, Cavalli R de C. Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia [Internet]. Hypertension in Pregnancy. 2019 ; 38( 2): 73-77.[citado 2024 jul. 28 ] Available from: https://doi.org/10.1080/10641955.2019.1582664
Vancouver
Sandrim VC, Coeli-Lacchini FB, Tanus-Santos JE, Lacchini R, Cavalli R de C. Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia [Internet]. Hypertension in Pregnancy. 2019 ; 38( 2): 73-77.[citado 2024 jul. 28 ] Available from: https://doi.org/10.1080/10641955.2019.1582664

Unidades USP

ReP

Filtros

Autores

Assuntos

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada